Evidence map›Paper›PMID 36896180›Full record

ArticleFrontiers in endocrinology2023

Julio C Ricarte-Filho, Victoria Casado-Medrano, Erin Reichenberger, Zachary Spangler, Michele Scheerer, Amber Isaza, Julia Baran, Tasleema Patel, Suzanne P MacFarland, Garrett M Brodeur and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Cancers · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Therapeutic Applications of Poly-miRNAs and miRNA Sponges.International journal of molecular sciences · 2025
    Review
  19. Review
  20. Cancers · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Julio C Ricarte-FilhoDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Victoria Casado-MedranoDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Erin ReichenbergerDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Zachary SpanglerDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Michele ScheererDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Amber IsazaDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Julia BaranDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Tasleema PatelDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Suzanne P MacFarlandDivision of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Garrett M BrodeurDivision of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Douglas R StewartDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
Zubair BalochDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Andrew J BauerDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Jonathan D WassermanDivision of Endocrinology, The Hospital for Sick Children, Toronto, ON, Canada.
Aime T FrancoDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
Philadelphia University · USUniversity of Pennsylvania · USChildren's Hospital of Philadelphia · USHospital for Sick Children · CANational Cancer Institute · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
RESEARCH AND MENTORING EXCELLENCE IN DIVERSE AND INCLUSIVE ENVIRONMENTR01CA214511 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI FRANCO, AIME T. · 2018 to 2023
$2.7M
NCI NIH HHS R01 CA214511NIEHS NIH HHS P30 ES013508
6 · The paper itself

Abstract

DICER1 is a highly conserved RNase III endoribonuclease essential for the biogenesis of single-stranded mature microRNAs (miRNAs) from stem-loop precursor miRNAs. Somatic mutations in the RNase IIIb domain of DICER1 impair its ability to generate mature 5p miRNAs and are believed to drive tumorigenesis in DICER1 syndrome-associated and sporadic thyroid tumors. However, the

Indexed as

MicroRNAsThyroid NeoplasmsChildDEAD-box RNA HelicasesHumansMitogen-Activated Protein KinasesMutationRibonuclease IIIRNA, MessengerThyroid Cancer, PapillaryDEAD-box RNA HelicasesDICER1 protein, humanMicroRNAsMitogen-Activated Protein KinasesRibonuclease IIIRNA, MessengercancerDICER1MAPKmicroRNAmutationpediatricRNAse IIIbthyroid

Identifiers

PMID36896180
PMCPMC9990750
OpenAlexW4321445994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.